Audio Recap: Timely Treatment for COVID-19
Hear expert insights on therapies under evaluation or authorized for the treatment of patients with COVID-19, including which antivirals to use and when, and how to operationalize administration of anti–SARS-CoV-2 monoclonal antibodies in the outpatient setting.
Decera Clinical Education Infectious Disease Podcast · Lynora Saxinger MD FRCPC CTropMed, Lynora Saxinger
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
During this episode, Lynora Saxinger, MD, FRCPC, CTropMed, updates listeners on the latest Emergency Use Authorizations and guideline recommendations for optimal clinical management of COVID-19. Gain practical insights on patient identification, risk stratification, and treatment.
Key points include:
- Treatment of COVID-19 can be broken into antiviral and immune-modulating therapies
- Each agent should be used at the correct disease stage to maximize benefit
- Antiviral medications and mAbs show the greatest promise early during COVID-19, before the host immune response is mounted
- Passive immunization with mAbs can prevent infection and severe disease—and mortality—if given early to hospitalized persons
- Operational challenges to using these medications exist, but given the epidemic of unvaccinated persons, these treatments become increasingly relevant to reduce burden on healthcare systems
Presenter:
Lynora Saxinger, MD, FRCPC, CTropMed
Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada
Content based on an online CME program supported by an educational grant from Gilead Sciences, Inc.
Follow along with the slides at:
https://bit.ly/3BxQKtD
Link to full program:
https://bit.ly/3BwzdlC
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.